Gene therapy effective for treating wet age-related macular degeneration: Study
Updated:6 years ago
Updated:6 years ago
New Delhi, Oct 15 (ANI): Recently developed gene therapy seems to be a promising alternative for treating one of the most common causes of blindness, wet age-related macular degeneration (AMD), claims a study. Researchers said the hope is that gene therapy will free patients from nearly monthly eye injections by offering a potential "one-and-done" treatment. It's not just about convenience; a more consistent treatment may also help people keep more of their vision. AMD is a degenerative eye disease that happens when part of the retina is damaged. The damage happens when new, weak blood vessels form behind the retina at the back of the eye. These abnormal vessels leak, causing scarring and killing off the cells that allow us to see. One main reason why is that patients are undertreated. This is because most people with AMD must go to the ophthalmologist's office every four to eight weeks for an injection directly into their eye (oftentimes in both eyes). This can be a difficult schedule to maintain for many elderly patients struggling with other maladies and reliant on others to get them to their ophthalmologist visits. It's also unsustainable for the health care system.
Updated:4 years, 9 months ago
Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan
Updated:4 years, 9 months ago
PM Modi joins world leaders in condemning US Capitol siege
Updated:4 years, 10 months ago
Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi
Updated:4 years, 10 months ago
Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan
Updated:4 years, 10 months ago
In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan
Updated:4 years, 10 months ago
Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India
 
  